Mirtazapine
Product Images NDC 70954-887

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70954-887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-1 (Container 1)

Mirtazapine Tablets, USP 7.5 mg label for a 30-tablet package by ANI Pharmaceuticals, Inc. The label includes dosage strength, storage instructions, a barcode, and a warning to keep medication out of reach of children. The issuance date is 04/2026.*

FDA Label Image

Label-2 (Label 2)

Mirtazapine Tablets, USP 15 mg in a 30-tablet package from ANI Pharmaceuticals, Inc. The label includes dosage strength, storage instructions, dispensing requirements, and a barcode. It advises dispensing the accompanying medication guide to patients and emphasizes keeping medication out of children's reach.*

FDA Label Image

Label-3 (Label 3)

Label for Mirtazapine Tablets USP 30 mg by ANI Pharmaceuticals, Inc. Includes NDC 70954-888-10, dispensing instructions, storage conditions, and a barcode. The label states to keep out of reach of children and to dispense the accompanying Medication Guide. The package contains 30 tablets.*

FDA Label Image

Label-4 (Label 4)

Label for Mirtazapine Tablets USP 45 mg, distributed by ANI Pharmaceuticals, Inc. It states Rx only, contains 30 tablets per container, and advises dispensing the accompanying Medication Guide. The label includes storage and dispensing instructions and a barcode, lot number, expiration date, and serial number area.*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Mirtazapine, featuring its characteristic fused ring system with nitrogen atoms and a methyl group.*

FDA Label Image

Table (Table)

This text panel lists behavioral and mood-related symptoms that may include suicidal thoughts, aggression, new or worsening depression, panic attacks, mania, anxiety, restlessness, trouble sleeping, and other unusual changes in mood or behavior.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.